Read full papers, extract experimental data and metadata, and see exactly what studies found.
Press Enter ↵ to solve
Fuel Your Discoveries
"The diversity of the phenomena of nature is so great, and the treasures hidden in the heavens so rich, precisely in order that the human mind shall never be lacking in fresh nourishment."
- Johannes Kepler
Quick Explanation
Copied
Key finding:
The TRPM4 inhibitor PBA is structurally assigned to two different binding pockets depending on temperature (8 °C vs 37 °C), with a ~12 Å relocation and a maintained triple π-stacking interaction, implying “temperature-dependent pharmacology plasticity.”
Caveat: the paper argues mechanism structurally, but does not directly link the pocket-switching to functional inhibition differences.
Primary paper:
Long Explanation
Paper review (BGPT) — Temperature-dependent ligand relocation reveals plasticity of TRPM4 inhibition
Publication date in provided record: May 14, 2026 • DOI: 10.64898/2026.05.13.724805
1) Visuals first: what changed with temperature?
Binding-pocket switch summary
Evidence basis (as stated in provided full text): PBA binds a canonical inhibitor pocket at 8 °C adjacent to S3/S4/S4–S5 linker/TRP helix, but relocates into the S1–S4 domain near the Ca2+ regulatory region at 37 °C; the ligand density shifts upward by ~12 Å, with preserved triple π-stacking interactions involving Trp864 and His908.
2) Data visualization from the provided extracted dataset
The provided record includes EMDB/PDB identifiers and reconstruction resolutions + particle counts. The plots below visualize those quantities to help assess data robustness and comparability across conditions.
Resolutions are taken directly from the supplied extracted dataset for EMDB/PDB maps.
Particle counts come from the supplied extracted dataset and align with Table 1 in the provided full text.
Interpretation is limited: yield depends on classification strategy and heterogeneity, not just experimental “quality.” Still, the very low final yield for PBA at 8 °C (16,154) suggests reconstructions may be more sensitive to modeling assumptions than those with larger final particle sets.
3) Evidence-based critique: what is strong vs uncertain?
Strengths (mechanistic clarity backed by structural controls)
Native-like lipid context comparison. The study compares TRPM4 in whole-cell vesicles and in GDN and reports that cholesterol-like paralipid densities are broadly similar (five shared sites) with one additional weaker site seen in vesicles. This supports the claim that detergent-solubilized preparations retain key features needed for ligand interpretation.
Temperature-linked relocation with explicit pocket assignment. The authors give residue-level pocket framing at both temperatures and quantify an approximate ligand positional shift (~12 Å), while also reporting that ligand density is present only in PBA-bound maps and not overlapping apo-only densities at the canonical site.
Conserved interaction motif across relocation. The work maintains a “same scaffold, different pocket” concept while retaining a triple π-stacking interaction involving Trp864 and His908, suggesting that not all interactions are rewired.
Key uncertainties / potential blind spots
No functional coupling to pocket switching. The paper explicitly does not determine functional consequences of the two PBA binding modes. Without ligand efficacy comparisons under strictly matching ionic/temperature conditions (and ideally site-directed mutations at the two pockets), the mechanistic link remains structural rather than causally pharmacological.
37 °C vesicle-derived reconstructions could not be obtained. The physiological-temperature binding pocket conclusion for the “native-like lipid” context relies on GDN-solubilized material at 37 °C, not on vesicles. The vesicle comparison is strongest at 8 °C, but that does not guarantee the same fidelity at 37 °C.
Occupancy vs binding mode probability. Cryo-EM assigns a ligand to specific densities in specific structures, but it does not directly quantify how much the channel population occupies each pocket under each condition. The analysis suggests ligand densities are well-defined in each map, yet the population distribution remains uncertain.
Generality to other anthranilic anilides is stated, not demonstrated. The authors suggest other anthranilic anilide inhibitors may use both sites, but this remains a prediction requiring direct testing.
4) How this fits the TRPM4 pharmacology literature (context check)
Temperature as a first-class pharmacology variable
Prior TRPM4 structural and functional work has emphasized temperature-dependent conformational ensembles affecting ligand recognition and gating. This paper extends that theme from “ligands bind different sites at 37 °C” to an explicit ligand relocation between two distinct pockets for PBA while using lipid-context comparisons (vesicles vs GDN).
Connection to prior inhibitor-pocket discovery (NBA/IBA)
The paper builds on earlier identification of an anthranilic anilide inhibitor pocket involving S3/S4/S4–S5 linker and the TRP helix for NBA/IBA. Here, PBA at 8 °C is assigned to that canonical pocket, aligning the new work with the earlier binding-site architecture, while adding a temperature-shifted alternative pocket at 37 °C.
5) Reproducibility & transparency checks
Public structural data. EMDB entries are provided for all four key maps (plus vesicle map) and PDB models are linked in the record, enabling third-party inspection of the fitted ligand density and pocket geometry.
Methodological detail present for purification and cryo-EM processing. The record includes expression, solubilization (GDN), vesicle preparation (sonication + DEAE + FLAG pull-down), cryo-EM acquisition parameters (e.g., Titan Krios 300 kV), and cryoSPARC processing steps with particle counts at major stages.
Remaining reproducibility caveat: fitting ligand and interpreting density overlap depend on local modeling choices; without raw map/metadata beyond EMDB, full reproducibility of the ligand assignment as an independent exercise still requires downloading and re-checking the density and fitting workflow from the deposited structures/maps.
6) Minimal “what would disprove this?” (falsification-oriented)
Single-pocket outcome under matching conditions. If re-analysis of the deposited maps (or new datasets under the same biochemical/temperature regime) does not reproduce two distinct ligand densities/pockets for PBA, then the relocation claim weakens.
Functional uncoupling. If PBA pocket mutations designed to disrupt one binding mode fail to change inhibition only at the corresponding temperature (while the other mode remains intact), then temperature-linked binding-mode differences would not causally explain inhibition behavior. (The current paper notes it does not yet establish functional consequence.)
7) Bespoke BGPT next-step links (authoritative targets for deeper queries)
Author reviews
Feedback:
Updated: June 05, 2026
BGPT Paper Review
Study Novelty
90%
The paper’s core novelty is not just confirming an inhibitor pocket, but showing a temperature-dependent ligand relocation for a single inhibitor scaffold (PBA) between two structurally distinct pockets, while also arguing detergent solubilization retains key paralipid features through a vesicle-vs-GDN comparison.
Scientific Quality
80%
High because it uses multiple structural conditions (apo vs PBA; 8 °C vs 37 °C with Ca2+) and includes a lipid-context control (vesicles vs GDN) with publicly deposited maps/models. Main quality risk: lack of direct functional validation connecting the two pocket modes to differential inhibition, and reliance on GDN for physiological-temperature lipid context because 37 °C vesicle data were not obtainable.
Study Generality
70%
Mechanistically informative for TRPM4 environment-aware pharmacology, but generalization to other inhibitors and to other channel family members is only predicted, not tested in the provided record.
Study Usefulness
80%
Useful for structure-guided TRPM4 inhibitor design because it refines where chemical scaffolds can engage under physiological conditions and highlights temperature as a driver of binding-site accessibility/arrangement. However, design guidance is constrained by missing functional mapping to the two binding modes.
Study Reproducibility
80%
Reproducible at the structural level because EMDB maps and PDB models are deposited for each key condition and the methods/pipelines are described (cryoSPARC processing steps, particle counts, refinement tools). Still, independent re-fitting/ligand-density re-evaluation is required for full reproducibility of the ligand assignment.
Explanatory Depth
80%
Mechanistically deep for structural pharmacology: it ties temperature to conformational ensemble/pocket accessibility and shows a consistent interaction motif while the pocket rearranges, yielding a coherent model. Explanatory depth is limited by not testing functional consequences of pocket occupancy at temperature.
It will scrape EMDB/PDB metadata for the TRPM4 conditions and plot resolution/particle-yield summaries to flag which datasets most strongly support the two-pocket claim.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
A “simple tight-binding increase with temperature” model is unlikely because the ligand density is assigned to a different pocket with a large positional shift (~12 Å) rather than a uniform strengthening within the canonical pocket.
“Vesicle-vs-GDN lipid mismatch causes an artifact pocket difference” is plausible but weakened by the reported overlap in cholesterol-binding patterns at 8 °C (five shared sites) and by the explicit apo-density non-overlap argument at the canonical site; however, the strongest counterpoint remains that 37 °C vesicle data were not obtained.
Quick Explanation
Long Explanation
Top Data Sources
ExportMCP
Keep Exploring
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Fuel Your Discoveries
Ask a Follow-Up
Key Insight
